Hong Kong stock abnormal fluctuation | Shisipharm Group (02005.HK) fell more than 7%, with a nearly 60% year-on-year decrease in net profit in the first quarter, and an expected 45% to 60% year-on-year decrease in mid-term net profit.
According to the Securities Times app, Sino Biopharmaceutical (02005.HK) fell more than 7% after its performance report. As of press time, the stock had dropped by 7.17% to HKD 2.72, with a turnover of HKD 5.2078 million.
Latest
